- The
Pharmacogenomics Knowledgebase (
PharmGKB) is a
publicly available,
online knowledge base
responsible for the aggregation, curation,
integration and...
-
Knowledgebase (
PharmGKB) is an "NIH-funded
resource that
provides information about how
human genetic variation affects response to medications.
PharmGKB collects...
- Acid-Lowering
Drugs Pathway, Pharmacodynamics".
PharmGKB.
Archived from the
original on 8
August 2014. "
PharmGKB".
Archived from the
original on 8
August 2014...
- CYP2D6
affects response to
medications can be
found in
databases such
PharmGKB,
Clinical Pharmacogenetics Implementation Consortium (CPIC). The variability...
- CYP2C9*1CYP2C9*13CYP2C9*3
related to zafirlukast".
PharmGKB.
Retrieved 29
November 2017. "CYP2C9
Allele Functionality Table".
PharmGKB.
Retrieved 29
November 2017. Goverdhan...
-
Julie A.
Johnson (2006-10-11). "Important
Variant Information for F5".
PharmGKB.
Archived from the
original on 2011-07-27.
Retrieved 2008-09-10. Juul,...
- S2CID 19666863.
Barbarino JM,
Haidar CE,
Klein TE,
Altman RB (March 2014). "
PharmGKB summary: very
important pharmacogene information for UGT1A1". Pharmacogenet...
-
Lamba J,
Sangkuhl K,
Thorn CF, Wang L,
Klein DJ, et al. (November 2014). "
PharmGKB summary:
gemcitabine pathway".
Pharmacogenetics and Genomics. 24 (11):...
-
analgesics Tapentadol Nortilidine O-AMKD TLR4
Tramadol Pharmacokinetics,
PharmGKB Sevcik J,
Nieber K,
Driessen B,
Illes P (September 1993). "Effects of the...
-
PharmGKB,
Clinical Pharmacogenetics Implementation Consortium (CPIC). The
label CYP2C9*1 is ****igned by the
Pharmacogene Variation Consortium (
PharmVar)...
